The Valley Desk

ArticleLeukemiaPublished

DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, Temple University, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Leukemia
Published
Subject terms
Cell Line, Tumor; Animals; Humans; Mice; Histone-Lysine N-Methyltransferase; Extracellular Signal-Regulated MAP Kinases; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-bcl-2; Xenograft Model Antitumor Assays; Apoptosis; Cell Proliferation; Myeloid-Lymphoid Leukemia Protein
PubMed ID
40148558
PubMed Central ID
PMC12055583
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal